Galectin-3 plasma levels in adult congenital heart disease and the pressure overloaded right ventricle: reason matters

Biomark Med. 2020 Sep;14(13):1197-1205. doi: 10.2217/bmm-2020-0250.

Abstract

Aim: To assess galectin-3 (Gal-3) levels and their relationship with clinical status and right ventricular (RV) performance in adults with RV pressure overload of various mechanisms due to congenital heart disease. Materials & methods: A cross-sectional study was conducted. Patients underwent clinical examination, blood testing and transthoracic echocardiography. Results: The study included 63 patients with congenitally corrected transposition of the great arteries, 41 patients with Eisenmenger syndrome and 20 healthy controls. Gal-3 concentrations were higher in patients compared with controls (7.83 vs 6.11 ng/ml; p = 0.002). Biomarker levels correlated with age, New York Health Association class, N-terminal probrain natriuretic peptide and RV function only in congenitally corrected transposition of the great arteries patients. Conclusion: Gal-3 profile in congenital heart disease patients and pressure-overloaded RV differs according to the cause of pressure overload.

Keywords: Eisenmenger syndrome; congenital heart disease; echocardiography; galectin-3; pulmonary arterial hypertension; right ventricle.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Cross-Sectional Studies
  • Echocardiography
  • Female
  • Galectin 3 / blood*
  • Heart Defects, Congenital / blood*
  • Heart Defects, Congenital / diagnostic imaging
  • Heart Ventricles / diagnostic imaging
  • Heart Ventricles / metabolism
  • Humans
  • Male
  • Middle Aged
  • Transposition of Great Vessels / blood
  • Transposition of Great Vessels / diagnostic imaging

Substances

  • Galectin 3